Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cardlytics, Inc. Director's Dealing 2018

Feb 9, 2018

33956_dirs_2018-02-08_c4f7b33a-980a-40a4-9cf5-199370a4853b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2018-02-08

Reporting Person: SOMERS KIRK (Chief Legal & Privacy Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee Stock Option (Right to Buy) $9.08 2024-08-01 Common Stock (37499) Direct
Employee Stock Option (Right to Buy) $20.00 2026-08-02 Common Stock (37335) Direct
Employee Stock Option (Right to Buy) $20.00 2026-12-06 Common Stock (12500) Direct
Employee Stock Option (Right to Buy) $30.44 2027-07-07 Common Stock (37500) Direct
Restricted Stock Unit $ Series G' Redeemable Convertible Preferred Stock (921) Direct
Restricted Stock Unit $ Series G' Redeemable Convertible Preferred Stock (1862) Direct
Restricted Stock Unit $ Series G' Redeemable Convertible Preferred Stock (1087) Direct

Footnotes

F1: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on June 14, 2015 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

F2: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on June 15, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

F3: This option became exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on December 6, 2017 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

F4: This option becomes exercisable with respect to one quarter (1/4) of the shares of stock subject to this option on April 1, 2018 (the "Initial Vesting Date"). The option becomes exercisable in respect of the remaining shares in thirty-six (36) equal monthly installments commencing one (1) month after the Initial Vesting Date, provided the Reporting Person continuously provides service to the Issuer through each vesting period.

F5: The restricted stock units (the "RSUs") will vest and settle upon the completion of the Issuer's initial public offering.

F6: Each RSU represents a contingent right to receive one share of the Issuer's Series G' Redeemable Convertible Preferred Stock